{"data":{"ticker":"BBIO","name":"BridgeBio Pharma, Inc.","cik":"0001743881","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":4091000,"netIncome":null,"epsDiluted":-1.08,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":1745000,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":211120000,"netIncome":null,"epsDiluted":-0.2,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":2168000,"netIncome":null,"epsDiluted":-0.39,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":2732000,"netIncome":null,"epsDiluted":-0.86,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":5882000,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":116633000,"netIncome":null,"epsDiluted":-0.88,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":110565000,"netIncome":null,"epsDiluted":-0.95,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":120700000,"netIncome":null,"epsDiluted":-0.95,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":154178000,"netIncome":null,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":194515000,"netIncome":null,"epsDiluted":-0.84,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":243676000,"netIncome":null,"epsDiluted":-0.78,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":8249000,"netIncome":null,"operatingCashFlow":-399714000,"capex":7518000,"buybacks":75000000,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":69716000,"netIncome":null,"operatingCashFlow":-497934000,"capex":13246000,"buybacks":200000000,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":77648000,"netIncome":null,"operatingCashFlow":-419494000,"capex":4821000,"buybacks":0,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":9303000,"netIncome":null,"operatingCashFlow":-527720000,"capex":1306000,"buybacks":0,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":221902000,"netIncome":null,"operatingCashFlow":-520726000,"capex":933000,"buybacks":0,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":502076000,"netIncome":null,"operatingCashFlow":-445910000,"capex":1097000,"buybacks":48276000,"dividends":null}],"latest":{"end":"2026-06-30","cash":677911000,"debt":2652873000,"equity":-2515215000,"assets":1217299000,"sharesOutstanding":195487474,"sharesDate":"2026-08-03","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/bbio"},"updatedAt":"2026-10-30T12:04:11.570Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bbio","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}